Table 3.
Univariable and multivariable analyses of factors in relation to overall survival
| Variables | Univariable | Multivariable | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| Age/years | ||||
| ≥ 60 versus < 60 | 1.072 (0.376–3.063) | 0.896 | ||
| Gender | ||||
| (M vs F) | 1.149 (0.351–3.7571) | 0.818 | ||
| BMI | ||||
| ≥ 25 versus < 25 | 1.055 (0.365–3.051) | 0.921 | ||
| Diabetes/hyperglycemia, n (%) | ||||
| Yes versus no | 1.182 (0.328–4.258) | 0.798 | ||
| TNM stage (AJCC 8th) | ||||
| III + IV versus I + II | 12.845 (4.417–37.353) | 0.001 | 4.859 (1.515–15.584) | 0.008 |
| Surgical type | ||||
| RN versus PN | 2.67 (0.744–9.583) | 0.132 | ||
| Tumor size (cm) | ||||
| ≥ 7 versus < 7 | 3.557 (1.24–10.205) | 0.018 | 1.819 (0.60–5.51) | 0.290 |
| Subtype, n (%) | ||||
| I versus II | 0.342 (0.106–1.098) | 0.071 | ||
| Serum album (g/l) | ||||
| < 40 versus ≥ 40 | 0.641 (0.214–1.92) | 0.427 | ||
| CHOL | ||||
| < 4.9 versus ≥ 4.9 | 0.988 (0.344–2.838) | 0.983 | ||
| NLR | ||||
| ≥ 2.39 versus < 2.39 | 12.007 (2.675–53.886) | 0.001 | 5.557 (1.059–29.149) | 0.043 |
| BUN/Cr | ||||
| ≥ 20 versus < 20 | 0.373 (0.082–1.706) | 0.203 | ||
TNM tumor-node-metastasis, CHOL cholesterol, NLR neutrophil-to-lymphocyte ratio, PN partial nephrectomy, RN radical nephrectomy